Position in BVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,064,499
+$5,657,192 QoQ
Shares Held
748,358
+385.5% QoQ
Ownership
0.890%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 155 holders
Holding Since
Mar 2021
3 quarters on record
Voting authority
Sole 0%
Shared 70%
None 30%
Common Shares in BVS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $7,924,963,064 across 31 Medical Devices names. BVS ranks #22 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
8,167,185 | $2,571,356,522 | |
| 2 | EW |
Edwards Lifesciences Corp
|
16,827,967 | $1,522,257,889 | |
| 3 | ABT |
Abbott Laboratories
|
8,304,709 | $753,569,291 | |
| 4 | STE |
STERIS plc
|
3,502,897 | $737,605,017 | |
| 5 | BSX |
Boston Scientific Corp
|
15,301,828 | $653,082,016 | |
| 6 | DXCM |
Dexcom Inc
|
8,527,471 | $574,325,169 | |
| 7 | MDT |
Medtronic plc
|
6,474,476 | $506,498,254 | |
| 8 | LIVN |
LivaNova PLC
|
1,739,167 | $143,011,699 |
All Filings in BVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,064,499 | 748,358 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,407,307 | 154,141 | Shares | Defined | 2026-05-15 | |
| 2021-03-31 | $220,047 | 14,401 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||